Skip to main content
UniHealth

Doctor search

Amer Karam Karam, MD

Gynecological Oncology · Stanford

NPI 1851308860

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Karam’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A87777 · Current

Licensed to practise in California · since 2004 · expires 2028-05-31 · American University of Beirut Faculty of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Good Samaritan Hospital
Clostridium Difficile (C.Diff)Infections0.337BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.84 (0.54 to 1.14)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths143.59 (98.7 to 188.49) · 98 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 45 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.7 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.3 · 573 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.6 · 820 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.5 · 482 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 3,711 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.12 (0 to 0.3) · 8,866 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.01 to 0.38) · 9,051 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.65 (0.74 to 4.56) · 1,929 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.8 (0.21 to 3.39) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.88 to 3.78) · 1,836 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.73 (0 to 13.46) · 669 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.58 (3.96 to 11.19) · 654 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.59 (0.13 to 3.04) · 496 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.27 (0 to 0.87) · 7,373 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 152 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections1.08No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.542No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.484No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.565No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 327 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits24.2 · 703 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits61.1 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits36.3 · 665 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits25.4 · 856 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 978 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.3 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.2 · 135 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.8 (10.1 to 18.6) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 531 casesNo differentJan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Patient survey stars by topic at Good Samaritan Hospital
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Good Samaritan Hospital
Room was "always" clean66%
Nurses "always" communicated well75%
Doctors "always" communicated well71%
Staff "always" explained54%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand66%
Doctors "always" listened carefully69%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications68%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night38%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects40%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$175,434

Medicare paid this office $175,434 for 352 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)138$25,029$104
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less24$19,460$811
Long return visit (40+ min)40$10,457$158
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes27$8,265$71
Return visit (30+ min)65$7,641$84
See all 14 services
Every Original Medicare service billed
Return visit (30+ min)138$25,029$104
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less24$19,460$811
Long return visit (40+ min)40$10,457$158
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes27$8,265$71
Return visit (30+ min)65$7,641$84
Short return visit (20+ min)81$5,660$62
Biopsy and removal of lymph nodes of abdominal cavity using an endoscope20$4,669$233
New patient visit (45+ min)35$4,361$125
Imaging of lymph nodes during surgery23$3,637$158
New patient visit (45+ min)28$2,945$105
Initial hospital care with moderate level of medical decision making at least 75 minutes15$2,851$150
Long return visit (40+ min)13$2,616$131
Short return visit (20+ min)39$2,143$52
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes12$1,866$117

Procedures Medicare counted

Procedure volume Medicare published
Removal of the uterus33More than 97% of doctors who do this

Who their Medicare patients are

352 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 8% · Also on Medicaid 26% · Health risk score 1.83. Above the middle of the specialty; the typical gynecological oncology clinician is at 1.53.

Conditions among them: High blood pressure 66% · Cancer 53% · Chronic kidney disease 20% · Depression 20% · Diabetes 19% · Coronary heart disease 19% · Heart failure 15% · Atrial fibrillation 13% · COPD 11% · Stroke 7% · Dementia 5%.

The office billed $1,171,367, Medicare allowed $223,875 and paid $175,434; for 1,015 services of 74 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243521,015731.83$1,171,367$175,434
2023319974731.65$895,671$147,954
2022281681721.79$602,772$106,817
2021330986721.91$1,069,197$173,744
20203301,174711.86$1,105,387$173,075
2019306911712.00$826,698$156,242
2018314975701.80$741,601$143,445
2017235795701.93$731,379$124,526
2016204607711.84$632,777$101,799
2015176608701.67$789,223$125,348
2014137398701.58$603,514$96,208
2013161306691.72$246,592$51,102

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 13 services

Original Medicare services billed in 2023
Return visit (30+ min)93$18,520$87
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less17$14,426$849
Return visit (30+ min)81$13,152$88
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes34$7,223$73
New patient visit (45+ min)43$5,122$119
Biopsy and removal of lymph nodes of abdominal cavity using an endoscope17$4,294$253
Short return visit (20+ min)63$4,054$51
Short return visit (20+ min)65$3,716$50
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes17$3,228$120
New patient visit (45+ min)27$3,191$118
Imaging of lymph nodes during surgery17$2,910$171
Long return visit (40+ min)14$2,527$133
Long return visit (40+ min)12$1,729$133

2022: 10 services

Original Medicare services billed in 2022
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less15$12,770$851
Return visit (30+ min)77$12,136$86
Return visit (30+ min)72$11,931$86
Short return visit (20+ min)50$3,302$52
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes24$3,243$66
Biopsy and removal of lymph nodes of abdominal cavity using an endoscope13$3,154$243
New patient visit (45+ min)24$2,867$119
New patient visit (45+ min)26$2,733$105
Short return visit (20+ min)45$2,641$49
Imaging of lymph nodes during surgery12$1,861$155

2021: 17 services

Original Medicare services billed in 2021
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less32$27,192$850
Return visit (30+ min)84$15,507$89
Return visit (30+ min)85$12,913$91
Biopsy and removal of lymph nodes of abdominal cavity using an endoscope27$6,880$255
Long return visit (40+ min)22$5,306$126
Imaging of lymph nodes during surgery32$5,221$163
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes31$5,105$65
Long return visit (40+ min)31$4,960$121
New patient visit (45+ min)36$4,582$127
Initial hospital care with moderate level of medical decision making at least 75 minutes18$4,256$185
Short return visit (20+ min)53$2,930$46
New patient visit (45+ min)21$2,528$120
New patient visit (60+ min)16$2,508$157
New patient visit (60+ min)14$2,372$169
Short return visit (20+ min)37$2,353$50
Short return visit12$548$34
Short return visit14$439$31

2020: 11 services

Original Medicare services billed in 2020
Return visit (30+ min)110$20,120$70
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes47$15,952$66
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less17$14,111$830
Return visit (30+ min)81$12,561$69
New patient visit (60+ min)50$7,270$145
Initial hospital care with moderate level of medical decision making at least 75 minutes29$5,936$185
New patient visit (60+ min)36$5,393$150
Biopsy and removal of lymph nodes of abdominal cavity using an endoscope15$3,242$216
Imaging of lymph nodes during surgery17$2,910$171
Short return visit (20+ min)53$2,683$43
Short return visit (20+ min)33$1,647$43

2019: 11 services

Original Medicare services billed in 2019
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less19$15,079$794
Return visit (30+ min)89$13,194$71
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes35$10,892$66
Return visit (30+ min)78$10,279$68
New patient visit (60+ min)51$7,455$146
Initial hospital care with moderate level of medical decision making at least 75 minutes21$4,956$184
New patient visit (60+ min)28$4,195$150
Biopsy and removal of lymph nodes of abdominal cavity using an endoscope17$3,684$217
Imaging of lymph nodes during surgery20$3,466$173
Short return visit (20+ min)36$1,476$39
Short return visit (20+ min)31$1,468$40

2018: 12 services

Original Medicare services billed in 2018
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less22$17,447$793
Return visit (30+ min)96$14,659$68
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes36$11,374$65
Return visit (30+ min)69$9,490$68
New patient visit (60+ min)57$7,953$140
New patient visit (60+ min)43$6,042$141
Initial hospital care with moderate level of medical decision making at least 75 minutes19$4,548$182
Biopsy and removal of lymph nodes of abdominal cavity using an endoscope14$3,194$228
Short return visit (20+ min)41$2,042$39
Short return visit (20+ min)39$1,943$40
Long return visit (40+ min)11$1,097$100
Other procedure on lymphatic system14$711$51

2017: 9 services

Original Medicare services billed in 2017
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less19$14,271$751
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes31$9,134$65
Return visit (30+ min)51$8,195$67
Return visit (30+ min)46$7,812$65
New patient visit (60+ min)45$6,652$148
New patient visit (60+ min)35$5,058$145
Initial hospital care with moderate level of medical decision making at least 75 minutes21$4,976$178
Short return visit (20+ min)47$2,859$43
Short return visit (20+ min)41$2,236$44

2016: 8 services

Original Medicare services billed in 2016
Return visit (30+ min)54$7,004$65
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes29$6,687$64
Return visit (30+ min)49$6,444$66
New patient visit (60+ min)35$5,081$145
New patient visit (60+ min)31$4,634$149
Initial hospital care with moderate level of medical decision making at least 75 minutes11$1,983$180
Short return visit (20+ min)29$1,504$42
Short return visit (20+ min)24$1,230$42

2015: 8 services

Original Medicare services billed in 2015
Return visit (30+ min)82$12,802$69
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less19$12,002$632
Removal of ovaries and/or tubes using an endoscope14$10,609$758
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes30$7,709$65
New patient visit (60+ min)49$7,306$149
New patient visit (60+ min)18$3,412$190
Return visit (30+ min)27$3,057$83
Long return visit (40+ min)20$1,989$99

2014: 8 services

Original Medicare services billed in 2014
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less15$13,993$933
Return visit (30+ min)42$6,223$70
New patient visit (60+ min)29$4,338$150
New patient visit (60+ min)23$4,333$188
Long return visit (40+ min)20$2,467$99
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes18$2,434$64
Return visit (30+ min)17$2,302$100
New patient visit (45+ min)11$1,272$116

2013: 6 services

Original Medicare services billed in 2013
New patient visit (60+ min)27$4,392$163
Short return visit (20+ min)48$3,068$57
Return visit (30+ min)30$2,813$83
New patient visit (45+ min)19$2,417$127
Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina21$1,333$61
Long return visit (40+ min)11$1,272$116

Medicaid work

$8,532 in 2024

Medicaid paid $8,532 for 138 billed services this clinician did in 2024, up to 17 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Return visit (30+ min)106$5,982
Long return visit (40+ min)14$1,416
Short return visit (20+ min)18$1,134
Medicaid work by year
2024138317$8,532
2023343225$11,854
2022241224$9,720
2021126218$5,174
2020226131$8,303
2019245235$7,343
2018271229$7,961
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Return visit (30+ min)248$9,652
Short return visit (20+ min)95$2,202

2022

Largest Medicaid services in 2022
Return visit (30+ min)177$8,009
Short return visit (20+ min)64$1,711

2021

Largest Medicaid services in 2021
Return visit (30+ min)111$4,892
Short return visit (20+ min)15$282

2020

Largest Medicaid services in 2020
Return visit (30+ min)226$8,303

2019

Largest Medicaid services in 2019
Return visit (30+ min)228$6,903
Short return visit (20+ min)17$441

2018

Largest Medicaid services in 2018
Return visit (30+ min)254$7,585
Short return visit (20+ min)17$376

Drugs they prescribed that Part D paid

$745,102

Pharmacies billed $745,102 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (12 of 424) in 2024. At or below the middle of the specialty; the typical gynecological oncology clinician is at 13%.

345 generic and 79 brand-name prescriptions · $745,102 in drug cost · 18 antibiotic prescriptions to 14 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lynparza33$354,487$10,742
Orserdu11$225,836$20,531
Prochlorperazine Maleate44$399$9
Ondansetron61$219$4
Lorazepam25$116$5
See all 9 drugs
Every Part D drug this clinician prescribed
Lynparza33$354,487$10,742
Orserdu11$225,836$20,531
Prochlorperazine Maleate44$399$9
Ondansetron61$219$4
Lorazepam25$116$5
Pantoprazole24$104$4
Metoclopramide23$97$4
Lisinopril13$78$6
Amlodipine Besylate13$29$2

Year by year

Part D prescribing by year
2024424953% (12)19%$745,102
2023281816% (18)None$367,703
2022287694% (12)19%$378,971
20213728910% (36)17%$681,754
2020501989% (47)17%$442,769
20194801186% (28)21%$663,646
20185861238% (45)None$540,609
2017306775% (15)None$143,145
2016233618% (18)14%$101,439
2015220607% (16)None$110,765
20141084319% (21)None$5,590
20131374510% (13)18%$16,614

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 6 drugs

Part D drugs prescribed in 2023
Lynparza17$210,342$12,373
Prochlorperazine Maleate35$354$10
Ondansetron38$242$6
Oxycodone15$126$8
Lorazepam18$96$5
Metoclopramide21$93$4

2022: 8 drugs

Part D drugs prescribed in 2022
Eliquis13$7,473$575
Premarin13$3,882$299
Medroxyprogesterone Acetate13$828$64
Ondansetron39$428$11
Prochlorperazine Maleate29$346$12
Tamoxifen Citrate11$230$21
Estradiol11$142$13
Metoclopramide19$68$4

2021: 8 drugs

Part D drugs prescribed in 2021
Rubraca18$242,058$13,448
Megestrol Acetate17$888$52
Prochlorperazine Maleate21$299$14
Ondansetron31$220$7
Tamoxifen Citrate15$217$14
Oxycodone23$198$9
Metoclopramide19$97$5
Estradiol16$81$5

2020: 13 drugs

Part D drugs prescribed in 2020
Rubraca21$276,476$13,166
Enoxaparin12$2,142$179
Letrozole17$721$42
Prochlorperazine Maleate42$696$17
Megestrol Acetate11$688$63
Oxycodone17$333$20
Ondansetron34$321$9
Tamoxifen Citrate12$242$20
Lorazepam30$110$4
Metoclopramide23$77$3
Hydrocodone-Acetaminophen11$72$7
Amlodipine Besylate13$58$4
Sulfamethoxazole-Trimethoprim11$47$4

2019: 17 drugs

Part D drugs prescribed in 2019
Rubraca22$267,099$12,141
Lynparza14$159,080$11,363
Zejula11$143,612$13,056
Eliquis13$6,195$477
Estradiol13$1,554$120
Tamoxifen Citrate11$494$45
Megestrol Acetate18$487$27
Letrozole16$413$26
Gabapentin16$366$23
Prochlorperazine Maleate32$325$10
Lidocaine-Prilocaine11$194$18
Ondansetron Odt18$141$8
Lorazepam29$138$5
Metoclopramide26$119$5
Oxycodone14$102$7
Ondansetron23$101$4
Amlodipine Besylate15$23$2

2018: 15 drugs

Part D drugs prescribed in 2018
Zejula14$182,062$13,004
Rubraca14$168,450$12,032
Lynparza17$161,506$9,500
Enoxaparin20$5,255$263
Estradiol18$1,515$84
Polyethylene Glycol 335017$478$28
Megestrol Acetate21$415$20
Ondansetron50$305$6
Prochlorperazine Maleate40$255$6
Ondansetron Odt30$247$8
Lorazepam46$193$4
Hydrocodone-Acetaminophen21$179$9
Oxycodone15$141$9
Metoclopramide25$122$5
Ibuprofen14$63$5

2017: 11 drugs

Part D drugs prescribed in 2017
Lynparza11$74,766$6,797
Enoxaparin15$5,307$354
Megestrol Acetate16$444$28
Sodium Chloride18$376$21
Ondansetron Odt15$155$10
Prochlorperazine Maleate18$112$6
Ondansetron19$99$5
Metoclopramide11$66$6
Lorazepam12$56$5
Ibu11$53$5
Ibuprofen11$41$4

2016: 3 drugs

Part D drugs prescribed in 2016
Enoxaparin13$5,246$404
Ondansetron27$241$9
Ibuprofen18$95$5

2015: 4 drugs

Part D drugs prescribed in 2015
Lynparza13$73,404$5,646
Ondansetron12$164$14
Ibuprofen20$116$6
Lorazepam14$49$3

2014: 2 drugs

Part D drugs prescribed in 2014
Hydrocodone-Acetaminophen17$186$11
Ibuprofen13$69$5

2013: 1 drug

Part D drugs prescribed in 2013
Estradiol15$288$19

Money from drug and device companies

$21,894 in 2025

Industry payments by year
2025429$20,060$21,894
2024615$4,175$7,069
2023313$10,102$11,731
2022422$26,650$29,135
2021321$28,733$29,311
2020319$21,975$22,576
2019543$39,308$46,610

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPLynparza$8,661
8 payments
  • Meals for Lynparza · 2025-12-04 · $121
  • Meals · 2025-08-27 · $12
  • Paid to speak or teach for Lynparza · 2025-07-24 · $3,280
  • Travel for Lynparza · 2025-07-24 · $22
  • Meals for Lynparza · 2025-07-17 · $125
  • Paid to speak or teach for Lynparza · 2025-03-20 · $4,920
  • Travel for Lynparza · 2025-03-14 · $65
  • Meals for Lynparza · 2025-03-10 · $115
Merck Sharp & DohmeKeytruda$6,015
6 payments
  • Travel for Keytruda · 2025-10-17 · $75
  • Paid to speak or teach for Keytruda · 2025-10-17 · $5,760
  • Meals for Keytruda · 2025-09-28 · $110
  • Meals for Keytruda · 2025-08-22 · $18
  • Meals for Keytruda · 2025-05-16 · $20
  • Meals for Keytruda · 2025-03-28 · $32
AbbvieElahere$3,807
9 payments
  • Meals for Elahere · 2025-10-07 · $39
  • Travel for Elahere · 2025-10-07 · $50
  • Consulting for Elahere · 2025-10-07 · $2,900
  • Travel for Elahere · 2025-10-07 · $24
  • Meals for Elahere · 2025-09-12 · $24
  • Travel for Elahere · 2025-09-12 · $321
  • Meals for Elahere · 2025-09-12 · $66
  • Meals for Elahere · 2025-09-11 · $77
  • Travel for Elahere · 2025-09-11 · $307
Corcept TherapeuticsNone$3,411
6 payments
  • Paid to speak or teach · 2025-12-23 · $3,200
  • Travel · 2025-12-23 · $26
  • Meals · 2025-12-23 · $8
  • Travel · 2025-12-23 · $48
  • Meals · 2025-12-13 · $50
  • Meals · 2025-12-13 · $80
See all 29 published payments
Every published payment
Corcept TherapeuticsPaid to speak or teach · 2025-12-23None$3,200
Corcept TherapeuticsTravel · 2025-12-23None$26
Corcept TherapeuticsMeals · 2025-12-23None$8
Corcept TherapeuticsTravel · 2025-12-23None$48
Corcept TherapeuticsMeals · 2025-12-13None$50
Corcept TherapeuticsMeals · 2025-12-13None$80
AstraZeneca Pharmaceuticals LPMeals · 2025-12-04Lynparza$121
Merck Sharp & DohmeTravel · 2025-10-17Keytruda$75
Merck Sharp & DohmePaid to speak or teach · 2025-10-17Keytruda$5,760
AbbvieMeals · 2025-10-07Elahere$39
AbbvieTravel · 2025-10-07Elahere$50
AbbvieConsulting · 2025-10-07Elahere$2,900
AbbvieTravel · 2025-10-07Elahere$24
Merck Sharp & DohmeMeals · 2025-09-28Keytruda$110
AbbvieMeals · 2025-09-12Elahere$24
AbbvieTravel · 2025-09-12Elahere$321
AbbvieMeals · 2025-09-12Elahere$66
AbbvieMeals · 2025-09-11Elahere$77
AbbvieTravel · 2025-09-11Elahere$307
AstraZeneca Pharmaceuticals LPMeals · 2025-08-27None$12
Merck Sharp & DohmeMeals · 2025-08-22Keytruda$18
AstraZeneca Pharmaceuticals LPPaid to speak or teach · 2025-07-24Lynparza$3,280
AstraZeneca Pharmaceuticals LPTravel · 2025-07-24Lynparza$22
AstraZeneca Pharmaceuticals LPMeals · 2025-07-17Lynparza$125
Merck Sharp & DohmeMeals · 2025-05-16Keytruda$20
Merck Sharp & DohmeMeals · 2025-03-28Keytruda$32
AstraZeneca Pharmaceuticals LPPaid to speak or teach · 2025-03-20Lynparza$4,920
AstraZeneca Pharmaceuticals LPTravel · 2025-03-14Lynparza$65
AstraZeneca Pharmaceuticals LPMeals · 2025-03-10Lynparza$115
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $7,069

Payments by company in 2024
AstraZeneca Pharmaceuticals LPLynparza$2,916
3 payments
  • Meals for Lynparza · 2024-12-18 · $129
  • Paid to speak or teach for Lynparza · 2024-08-27 · $2,750
  • Meals for Lynparza · 2024-07-10 · $38
Intuitive SurgicalDa Vinci Surgical System$2,540
2 payments
  • Travel for Da Vinci Surgical System · 2024-03-08 · $40
  • Education for Da Vinci Surgical System · 2024-02-28 · $2,500
EMD Serono Research & Development InstituteNone$1,425
1 payment
  • Consulting · 2024-01-01 · $1,425
Merck Sharp & DohmeLynparza$95
4 payments
  • Meals for Lynparza · 2024-12-20 · $34
  • Meals for Lynparza · 2024-10-11 · $19
  • Meals for Lynparza · 2024-08-23 · $23
  • Meals for Lynparza · 2024-06-21 · $19
GlaxoSmithKlineZejula$65
1 payment
  • Education for Zejula · 2024-09-09 · $65
Ethicon USSurgiflo Hemostatic Matrix$28
1 payment
  • Meals for Surgiflo Hemostatic Matrix · 2024-07-16 · $28

2023: $11,731

Payments by company in 2023
AstraZeneca Pharmaceuticals LPLynparza$6,943
3 payments
  • Paid to speak or teach for Lynparza · 2023-03-20 · $4,100
  • Paid to speak or teach for Lynparza · 2023-03-13 · $2,750
  • Meals for Lynparza · 2023-03-06 · $93
GlaxoSmithKlineJemperli$3,237
8 payments
  • Meals for Zejula · 2023-09-21 · $5
  • Meals for Zejula · 2023-08-11 · $8
  • Paid to speak or teach for Jemperli · 2023-05-10 · $1,600
  • Meals for Zejula · 2023-04-17 · $9
  • Meals for Zejula · 2023-03-13 · $5
  • Paid to speak or teach for Jemperli · 2023-02-08 · $400
  • Meals for Zejula · 2023-02-06 · $10
  • Paid to speak or teach for Zejula · 2023-01-18 · $1,200
Intuitive SurgicalDa Vinci Surgical System$1,552
2 payments
  • Paid to speak or teach for Da Vinci Sp · 2023-12-13 · $52
  • Education for Da Vinci Surgical System · 2023-12-08 · $1,500

2022: $29,135

Payments by company in 2022
GlaxoSmithKlineZejula$27,801
18 payments
  • Paid to speak or teach for Zejula · 2022-12-21 · $4,800
  • Meals for Zejula · 2022-12-12 · $90
  • Travel for Zejula · 2022-08-25 · $58
  • Travel for Zejula · 2022-07-08 · $55
  • Paid to speak or teach for Zejula · 2022-06-29 · $4,800
  • Meals for Zejula · 2022-06-14 · $119
  • Paid to speak or teach for Zejula · 2022-05-18 · $4,800
  • Meals for Zejula · 2022-05-11 · $17
  • Travel for Zejula · 2022-05-11 · $11
  • Paid to speak or teach for Zejula · 2022-05-11 · $1,600
  • Paid to speak or teach for Zejula · 2022-04-27 · $2,400
  • Travel for Zejula · 2022-04-27 · $34
  • Meals for Zejula · 2022-04-27 · $20
  • Paid to speak or teach for Zejula · 2022-04-13 · $4,800
  • Travel for Zejula · 2022-03-31 · $1,634
  • Meals for Zejula · 2022-03-31 · $66
  • Meals for Zejula · 2022-03-23 · $97
  • Paid to speak or teach for Zejula · 2022-03-09 · $2,400
AstraZeneca Pharmaceuticals LPLynparza$1,050
1 payment
  • Paid to speak or teach for Lynparza · 2022-07-11 · $1,050
ConmedAirseal$269
2 payments
  • Meals for Airseal · 2022-03-03 · $138
  • Meals for Airseal · 2022-02-28 · $131
PfizerNone$15
1 payment
  • Meals · 2022-08-06 · $15

2021: $29,311

Payments by company in 2021
GlaxoSmithKlineZejula$17,283
12 payments
  • Paid to speak or teach for Zejula · 2021-12-21 · $4,800
  • Travel for Zejula · 2021-12-21 · $57
  • Meals for Zejula · 2021-12-09 · $119
  • Paid to speak or teach for Zejula · 2021-11-11 · $800
  • Meals for Zejula · 2021-10-15 · $8
  • Paid to speak or teach for Zejula · 2021-09-22 · $4,800
  • Travel for Zejula · 2021-09-22 · $40
  • Meals for Zejula · 2021-09-14 · $120
  • Meals for Zejula · 2021-07-16 · $17
  • Paid to speak or teach for Zejula · 2021-06-03 · $4,800
  • Meals for Zejula · 2021-05-20 · $122
  • Paid to speak or teach for Zejula · 2021-05-13 · $1,600
AstraZeneca Pharmaceuticals LPLynparza$8,828
7 payments
  • Paid to speak or teach for Lynparza · 2021-12-19 · $200
  • Consulting for Lynparza · 2021-10-06 · $2,398
  • Paid to speak or teach for Lynparza · 2021-10-04 · $1,350
  • Paid to speak or teach for Lynparza · 2021-08-10 · $2,750
  • Meals for Lynparza · 2021-08-05 · $95
  • Paid to speak or teach for Lynparza · 2021-04-27 · $1,350
  • Consulting for Lynparza · 2021-01-20 · $685
Clovis OncologyRubraca$3,200
2 payments
  • Consulting for Rubraca · 2021-11-18 · $1,600
  • Consulting for Rubraca · 2021-09-15 · $1,600

2020: $22,576

Payments by company in 2020
AstraZeneca Pharmaceuticals LPLynparza$7,798
7 payments
  • Paid to speak or teach for Lynparza · 2020-09-22 · $1,350
  • Paid to speak or teach for Lynparza · 2020-07-21 · $1,350
  • Paid to speak or teach for Lynparza · 2020-06-02 · $600
  • Paid to speak or teach for Lynparza · 2020-03-26 · $2,400
  • Paid to speak or teach for Lynparza · 2020-02-06 · $2,050
  • Meals for Lynparza · 2020-01-30 · $16
  • Travel for Lynparza · 2020-01-30 · $32
GlaxoSmithKlineZejula$7,671
4 payments
  • Paid to speak or teach for Zejula · 2020-11-12 · $4,800
  • Meals for Zejula · 2020-10-28 · $71
  • Paid to speak or teach for Zejula · 2020-07-16 · $1,600
  • Paid to speak or teach for Zejula · 2020-05-28 · $1,200
Clovis OncologyRubraca$7,107
8 payments
  • Paid to speak or teach for Rubraca · 2020-09-22 · $1,500
  • Consulting for Rubraca · 2020-07-29 · $2,125
  • Consulting for Rubraca · 2020-05-21 · $3,000
  • Travel for Rubraca · 2020-04-21 · $121
  • Travel for Rubraca · 2020-04-21 · $65
  • Travel for Rubraca · 2020-04-21 · $213
  • Travel for Rubraca · 2020-04-21 · $65
  • Education for Rubraca · 2020-01-22 · $18

2019: $46,610

Payments by company in 2019
Clovis OncologyRubraca$40,962
36 payments
  • Paid to speak or teach for Rubraca · 2019-09-23 · $2,500
  • Paid to speak or teach for Rubraca · 2019-09-18 · $3,500
  • Meals for Rubraca · 2019-09-16 · $125
  • Travel for Rubraca · 2019-09-11 · $534
  • Meals for Rubraca · 2019-09-11 · $20
  • Paid to speak or teach for Rubraca · 2019-07-31 · $1,000
  • Paid to speak or teach for Rubraca · 2019-07-26 · $750
  • Paid to speak or teach for Rubraca · 2019-07-25 · $2,500
  • Meals for Rubraca · 2019-07-10 · $125
  • Consulting for Rubraca · 2019-07-08 · $1,000
  • Paid to speak or teach for Rubraca · 2019-06-24 · $5,000
  • Paid to speak or teach for Rubraca · 2019-06-24 · $4,000
  • Paid to speak or teach for Rubraca · 2019-06-24 · $2,000
  • Travel for Rubraca · 2019-06-19 · $481
  • Travel for Rubraca · 2019-06-19 · $122
  • Travel for Rubraca · 2019-06-19 · $465
  • Meals for Rubraca · 2019-06-19 · $118
  • Travel for Rubraca · 2019-06-19 · $481
  • Travel for Rubraca · 2019-06-19 · $122
  • Travel for Rubraca · 2019-06-19 · $523
  • Meals for Rubraca · 2019-06-19 · $11
  • Travel for Rubraca · 2019-06-13 · $233
  • Travel for Rubraca · 2019-06-13 · $472
  • Meals for Rubraca · 2019-06-13 · $125
  • Paid to speak or teach for Rubraca · 2019-05-21 · $750
  • Paid to speak or teach for Rubraca · 2019-05-21 · $4,000
  • Travel for Rubraca · 2019-05-01 · $1,007
  • Meals for Rubraca · 2019-05-01 · $100
  • Paid to speak or teach for Rubraca · 2019-03-28 · $3,500
  • Travel for Rubraca · 2019-03-20 · $807
  • Meals for Rubraca · 2019-03-20 · $125
  • Consulting for Rubraca · 2019-03-11 · $3,500
  • Travel for Rubraca · 2019-02-23 · $563
  • Meals for Rubraca · 2019-02-23 · $141
  • Travel for Rubraca · 2019-02-22 · $137
  • Meals for Rubraca · 2019-02-22 · $125
AstraZeneca Pharmaceuticals LPLynparza$3,383
2 payments
  • Paid to speak or teach for Lynparza · 2019-11-13 · $300
  • Consulting for Lynparza · 2019-10-23 · $3,083
TesaroZejula$1,925
1 payment
  • Paid to speak or teach for Zejula · 2019-12-17 · $1,925
Intuitive SurgicalDa Vinci Surgical System$211
2 payments
  • Meals for Da Vinci Surgical System · 2019-06-14 · $75
  • Meals for Da Vinci Surgical System · 2019-05-24 · $136
Merck Sharp & DohmeLynparza$130
2 payments
  • Meals for Lynparza · 2019-10-21 · $65
  • Meals · 2019-09-25 · $65

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
AstraZeneca UK Limited · A Phase 2a Randomized Double Blind Placebo-Controlled Study To Evaluate the Efficacy and Safety of Medi3506 in Subjects With Diabetic Kidney Disease · 2022Their institution$9,188
AstraZeneca Pharmaceuticals LP · A Phase 2a Randomized Double Blind Placebo-Controlled Study To Evaluate the Efficacy and Safety of Medi3506 in Subjects With Diabetic Kidney Disease · 2022Their institution$3,653

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1851308860
Licence
CA A87777California A87777: Current · expires 2028-05-31
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00A877770
Taxonomy
Federal specialty code 207VX0201X (207VX0201X); Federal specialty code 207V00000X (207V00000X); Federal specialty code 207VH0002X (207VH0002X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-08-02
NPI last updated
2024-04-26
NPI record certified
2024-04-26

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 2589 Samaritan Dr, San Jose, CA, 95124